Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.

News | Radiopharmaceuticals and Tracers

November 3, 2015 — Australian immuno-oncology company Minomic International Ltd has struck an agreement to launch the ...

Time November 03, 2015
arrow
News | PET-CT

November 3, 2015 — The University of Tennessee Medical Center announced it has implemented new software aimed at ...

Time November 03, 2015
arrow
Technology | Radiation Therapy

October 20, 2015 — In October, Siemens Healthcare debuted a host of imaging systems that enable radiation therapy (RT) ...

Time October 20, 2015
arrow
News | Radiopharmaceuticals and Tracers

October 19, 2015 — Siemens’ PETNET Solutions Inc., a wholly owned subsidiary of Siemens Healthcare, will formulate the ...

Time October 19, 2015
arrow
Technology | Nuclear Imaging

October 14, 2015 — Gamma Medica Inc. announced the CE Mark approval allowing for the sale and distribution of the ...

Time October 14, 2015
arrow
News | Radiopharmaceuticals and Tracers

October 2, 2015 — Siemens’ PETNET Solutions has received Abbreviated New Drug Application (ANDA) approval from the U.S ...

Time October 02, 2015
arrow
News | PET Imaging

September 23, 2015 — New research describes a method, tested in rats, that may someday allow healthcare providers to ...

Time September 23, 2015
arrow
News | SPECT Imaging

September 23, 2015 — The World Molecular Imaging Society (WMIS) presented the first annual Commercial Innovation of the ...

Time September 23, 2015
arrow
Blog | Computed Tomography (CT)

They were once the kings of computed tomography (CT) — 16-slice scanners that hinted at coronary CT angiography; 64 ...

Time September 22, 2015
arrow
News | Radiopharmaceuticals and Tracers

September 18, 2015 — A recently developed drug was significantly better at detecting recurring prostate cancer in early ...

Time September 18, 2015
arrow
News | Radiopharmaceuticals and Tracers

September 17, 2015 — At the National Nuclear Security Administration’s (NNSA) 2015 Mo-99 Topical Meeting, Novation ...

Time September 17, 2015
arrow
News | Radiopharmaceuticals and Tracers

September 16, 2015 — A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the ...

Time September 16, 2015
arrow
News | Prostate Cancer

September 14, 2015 — ImaginAb Inc. has released interim results from a Phase 2 clinical trial of IAB2M, the company's ...

Time September 14, 2015
arrow
News | Radiopharmaceuticals and Tracers

September 11, 2015 — Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and ...

Time September 11, 2015
arrow
News | Radiopharmaceuticals and Tracers

September 11, 2015 — Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of ...

Time September 11, 2015
arrow
Feature | AAPM | Melinda Taschetta-Millane

During the recent American Association of Physicists in Medicine (AAPM) conference in Anaheim, Calif., I had the ...

Time September 08, 2015
arrow
News | Radiopharmaceuticals and Tracers

September 3, 2015 — Navidea Biopharmaceuticals Inc. received initial notice of award for a Fast Track Small Business ...

Time September 03, 2015
arrow
News | Radiopharmaceuticals and Tracers

August 31, 2015 — NorthStar Medical Radioisotopes LLC has received approval to begin routine production of molybdenum-99 ...

Time August 31, 2015
arrow
News | Prostate Cancer

August 21, 2015 — A molecular imaging biomarker is able to detect fast-growing primary prostate cancer and distinguish ...

Time August 21, 2015
arrow
News | Radiopharmaceuticals and Tracers

August 20, 2015 — The ITM Group announced that its subsidiary ITG GmbH has successfully in-licensed DOTA-Zoledronate, a ...

Time August 20, 2015
arrow
Subscribe Now